Methyl imidazo[1,2-a]pyridine-8-carboxylate
97%
- Product Code: 209012
CAS:
133427-07-3
| Molecular Weight: | 176.17 g./mol | Molecular Formula: | C₉H₈N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09842621 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry seal |
Product Description:
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anxiolytic and sedative agents. Its structure supports binding to benzodiazepine receptors, making it valuable in central nervous system drug research. Also employed in the preparation of kinase inhibitors for potential use in cancer therapy. Commonly utilized in medicinal chemistry for scaffold modification to enhance drug potency and selectivity.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | £16.46 |
+
-
|
| 5.000 | 10-20 days | £62.87 |
+
-
|
| 10.000 | 10-20 days | £123.45 |
+
-
|
| 25.000 | 10-20 days | £251.47 |
+
-
|
Methyl imidazo[1,2-a]pyridine-8-carboxylate
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anxiolytic and sedative agents. Its structure supports binding to benzodiazepine receptors, making it valuable in central nervous system drug research. Also employed in the preparation of kinase inhibitors for potential use in cancer therapy. Commonly utilized in medicinal chemistry for scaffold modification to enhance drug potency and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :